156 related articles for article (PubMed ID: 916187)
21. [Clinical experience with S-6436 in urinary tract infections (author's transl)].
Yamamoto H; Oida S; Ohtsuki A; Hosomi T; Kubo Y
Jpn J Antibiot; 1977 Oct; 30(10):825-8. PubMed ID: 592485
[TBL] [Abstract][Full Text] [Related]
22. [Clinical investigations of cefadroxil in the infections of children (author's transl)].
Sugaya N; Ichihashi H
Jpn J Antibiot; 1981 Feb; 34(2):157-60. PubMed ID: 7253195
[TBL] [Abstract][Full Text] [Related]
23. [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections].
Aonuma S; Oizumi K; Watanabe A; Tokue Y; Honda Y; Ono R; Kitamura N; Konno K; Satoh K
Jpn J Antibiot; 1988 Sep; 41(9):1309-12. PubMed ID: 3241329
[TBL] [Abstract][Full Text] [Related]
24. [Clinical experience with sustained release cefalexin (author's transl)].
Takada K
Jpn J Antibiot; 1977 Oct; 30(10):793-801. PubMed ID: 592481
[TBL] [Abstract][Full Text] [Related]
25. [Long-acting cefalexin preparation (S-6436): pharmacokinetics and clinical evaluation (author's transl)].
Saito A; Kato Y; Tomizawa M; Nakayama I
Kansenshogaku Zasshi; 1977 Jun; 51(6):303-11. PubMed ID: 411842
[No Abstract] [Full Text] [Related]
26. [Some investigations on cefadroxil dry syrup (author's transl)].
Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Hirama Y; Narita A; Chikaoka H; Yamaguchi T
Jpn J Antibiot; 1981 Feb; 34(2):171-9. PubMed ID: 7253197
[TBL] [Abstract][Full Text] [Related]
27. [Fundamental and clinical studies on S-6436 (author's transl)].
Nasu M; Nakatomi M; Hirota M; Nagasawa T; Horiuchi N
Kansenshogaku Zasshi; 1977 Jul; 51(7):371-6. PubMed ID: 411852
[No Abstract] [Full Text] [Related]
28. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
Furusawa T; Tanaka S
Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
[TBL] [Abstract][Full Text] [Related]
29. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
[TBL] [Abstract][Full Text] [Related]
30. [Fundamental and clinical studies on cefadroxil dry syrup in children (author's transl)].
Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
Jpn J Antibiot; 1981 Jan; 34(1):33-40. PubMed ID: 7241805
[TBL] [Abstract][Full Text] [Related]
31. [Clinical experience with sustained release cefalexin (S-6436) in surgery (author's transl)].
Takenaka M; Tanimura H; Kamata T; Setoyama M
Jpn J Antibiot; 1977 Nov; 30(11):893-7. PubMed ID: 592490
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of long-acting preparation of cephalexin (S-6436) in the treatment of acute tonsillitis and acute otitis media--a double blind study (author's transl)].
Baba S; Ito H; Tsukiyama M; Iwata S; Nishimura T
Kansenshogaku Zasshi; 1977 Jun; 51(6):286-302. PubMed ID: 411841
[No Abstract] [Full Text] [Related]
33. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
Hori M; Toyonaga Y; Kurosu Y; Kumagai K
Jpn J Antibiot; 1981 Jan; 34(1):61-76. PubMed ID: 7241807
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of pulmonary infections with cephalexin (author's transl)].
Götz M; Klabuschnigg A
Padiatr Padol; 1978; 13(2):221-5. PubMed ID: 643299
[TBL] [Abstract][Full Text] [Related]
35. [Bioavailability of new galenic preparations of cephalexin (author's transl)].
Guggenbichler JP; Kienel G
Padiatr Padol; 1978; 13(3):315-20. PubMed ID: 673437
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation on S-6436 (author's transl)].
Suzuki H; Iwasaki H; Ra S; Matsumoto K
Kansenshogaku Zasshi; 1977 Jun; 51(6):317-20. PubMed ID: 411844
[No Abstract] [Full Text] [Related]
37. [Clinical evaluation of S-6437 in pediatric patients with acute pharyngitis and tonsillitis. Comparative double blind studies with regular cephalexin].
Uchida K; Sakano Y; Shimizu S; Nishida T; Fukuda M; Makino I
Jpn J Antibiot; 1977 Dec; 30(12):973-92. PubMed ID: 340724
[No Abstract] [Full Text] [Related]
38. [Clinical studies on cefadroxil in the field of pediatrics].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Suzuki K; Yuasa T; Tanaka Y; Tsugawa S; Nagayama K; Yamamoto M; Komatsu Y; Koga M; Ohta M; Tanaka M; Takasaki Y; Nagai T
Jpn J Antibiot; 1983 Jan; 36(1):93-102. PubMed ID: 6842830
[TBL] [Abstract][Full Text] [Related]
39. [Clinical investigation of cefadroxil in pediatric field (author's transl)].
Nanri S; Jozaki K; Hattori H; Hotta M; Akita H; Yamashita N; Sunakawa K; Oikawa T; Ichihashi Y; Takahashi H; Iwata S; Kori T
Jpn J Antibiot; 1981 Feb; 34(2):152-6. PubMed ID: 7253194
[TBL] [Abstract][Full Text] [Related]
40. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
Leveque B; Lambert-Zechovsky N; Cathlin C
Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
